Interestingly, HDAC inhibitors have been proven effective in several types of cancer [85,86,87,88] and represent a promising therapy for non-oncological diseases, including neurodegeneration, inflammation, and cardiovascular diseases [84,89]. Here, HDAC9 is linked to cardiovascular disorder.